BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37031346)

  • 21. Hyperthermia enhances thermal-neutron-induced cell death of human glioblastoma cell lines at low concentrations of 10B.
    Kinashi Y; Masunaga SI; Suzuki M; Ono K; Ohnishi T
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1185-92. PubMed ID: 9539576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase.
    Carruthers R; Ahmed SU; Strathdee K; Gomez-Roman N; Amoah-Buahin E; Watts C; Chalmers AJ
    Mol Oncol; 2015 Jan; 9(1):192-203. PubMed ID: 25205037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Boron neutron capture therapy for malignant gliomas.
    Diaz AZ; Coderre JA; Chanana AD; Ma R
    Ann Med; 2000 Feb; 32(1):81-5. PubMed ID: 10711581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment.
    Chaudhary P; Marshall TI; Perozziello FM; Manti L; Currell FJ; Hanton F; McMahon SJ; Kavanagh JN; Cirrone GA; Romano F; Prise KM; Schettino G
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):27-35. PubMed ID: 24986743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial.
    Combs SE; Kieser M; Rieken S; Habermehl D; Jäkel O; Haberer T; Nikoghosyan A; Haselmann R; Unterberg A; Wick W; Debus J
    BMC Cancer; 2010 Sep; 10():478. PubMed ID: 20819220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.
    Wang P; Zhen H; Jiang X; Zhang W; Cheng X; Guo G; Mao X; Zhang X
    BMC Cancer; 2010 Dec; 10():661. PubMed ID: 21122152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies.
    Li R; Wang H; Liang Q; Chen L; Ren J
    Biomater Sci; 2022 Feb; 10(4):892-908. PubMed ID: 34989724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deregulated MicroRNA Signature Following Glioblastoma Irradiation.
    Toraih EA; El-Wazir A; Abdallah HY; Tantawy MA; Fawzy MS
    Cancer Control; 2019; 26(1):1073274819847226. PubMed ID: 31046428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BK channels blockage inhibits hypoxia-induced migration and chemoresistance to cisplatin in human glioblastoma cells.
    Rosa P; Catacuzzeno L; Sforna L; Mangino G; Carlomagno S; Mincione G; Petrozza V; Ragona G; Franciolini F; Calogero A
    J Cell Physiol; 2018 Sep; 233(9):6866-6877. PubMed ID: 29319175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma.
    Narayan RS; Gasol A; Slangen PLG; Cornelissen FMG; Lagerweij T; Veldman HYYE; Dik R; van den Berg J; Slotman BJ; Würdinger T; Haas-Kogan DA; Stalpers LJA; Baumert BG; Westerman BA; Theys J; Sminia P
    Mol Cancer Ther; 2018 Feb; 17(2):347-354. PubMed ID: 28958992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor cell-targeting radiotherapy in the treatment of glioblastoma multiforme using linear accelerators.
    Chiang CS; Shih IJ; Shueng PW; Kao M; Zhang LW; Chen SF; Chen MH; Liu TY
    Acta Biomater; 2021 Apr; 125():300-311. PubMed ID: 33609743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT.
    Matsumura A; Yamamoto T; Tsurubuchi T; Matsuda M; Shirakawa M; Nakai K; Endo K; Tokuue K; Tsuboi K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of low energy protons on clonogenic survival, DSB repair and cell cycle in human glioblastoma cells and B14 fibroblasts.
    Moertel H; Georgi JC; Distel L; Eyrich W; Fritsch M; Grabenbauer G; Sauer R
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S115-8. PubMed ID: 15971324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arginine Deprivation Therapy: Putative Strategy to Eradicate Glioblastoma Cells by Radiosensitization.
    Hinrichs CN; Ingargiola M; Käubler T; Löck S; Temme A; Köhn-Luque A; Deutsch A; Vovk O; Stasyk O; Kunz-Schughart LA
    Mol Cancer Ther; 2018 Feb; 17(2):393-406. PubMed ID: 28830984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells.
    Castro-Gamero AM; Borges KS; Moreno DA; Suazo VK; Fujinami MM; de Paula Gomes Queiroz R; de Oliveira HF; Carlotti CG; Scrideli CA; Tone LG
    Invest New Drugs; 2013 Aug; 31(4):858-70. PubMed ID: 23299390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells.
    Talarico C; Dattilo V; D'Antona L; Barone A; Amodio N; Belviso S; Musumeci F; Abbruzzese C; Bianco C; Trapasso F; Schenone S; Alcaro S; Ortuso F; Florio T; Paggi MG; Perrotti N; Amato R
    Oncotarget; 2016 Mar; 7(13):15868-84. PubMed ID: 26908461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiosensitization of Primary Human Glioblastoma Stem-like Cells with Low-Dose AKT Inhibition.
    Mehta M; Khan A; Danish S; Haffty BG; Sabaawy HE
    Mol Cancer Ther; 2015 May; 14(5):1171-80. PubMed ID: 25695954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.
    Britten RA; Nazaryan V; Davis LK; Klein SB; Nichiporov D; Mendonca MS; Wolanski M; Nie X; George J; Keppel C
    Radiat Res; 2013 Jan; 179(1):21-8. PubMed ID: 23148508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.